STVN: Stevanato Group Corp Projected Price to Earnings

Brandmark of Stevanato Group S.p.A. (STVN)

The forward P/E ratio chart for Stevanato Group S.p.A. (STVN) demonstrates the impact of cost standards for sterile container transport. Strategic alliances with pharma behemoths to implement biologics and a steady cash flow from the production of exclusive cartridges support the rise in share prices. The value of 21.60 serves as the current metric, capturing market expectations regarding the future stock value of Stevanato Group S.p.A.

STVN - Stevanato Group Market Cap to Projected Earnings over the range 07/04/2022 - 11/15/2026

Analytical breakdowns and data insights for company Stevanato Group (STVN)

- stock value and consensus price forecast:
Summary company analysis:STVN Stevanato
Signature product of stevanatogroup.com

For an objective valuation of Stevanato Group S.p.A. (STVN), it is necessary to analyze the ratio of the current price to expected earnings, which reflects market expectations for future revenues. By examining the company's forward P/E valuation, an investor can discern the extent of earnings revisions, which for Stevanato Group S.p.A. (STVN) are stabilized by FDA certification inertia, guaranteeing multi-year vial supply contracts and confirming the high reliability of the issuer's capital.

Direct competitors

Future Price to Earnings Intuitive Surgical Inc (ISRG)|DHR (Danaher Corp) - Future Price to Earnings Multiple|Forward P/E Multiple BDX (bd.com)|Market Cap to Projected Earnings steris.com (STE)|WST - Future Price to Earnings|BAX (Baxter International Inc.) - Price to Future Earnings Ratio|Masimo Corporation (MASI) - Future Price to Earnings|TFX - Market Cap to Projected Earnings|Future Price to Earnings merit.com|Envista (NVST) - Market Cap to Projected Earnings|Projected Price to Earnings ICUI (ICU Medical, Inc.)|Market Cap to Future Earnings Ratio XRAY|Future Price to Earnings LeMaitre LMAT|Future Price to Earnings Multiple ATRC|STAA: Projected Price to Earnings|NAGE - Forward P/E Multiple|ZimVie Inc (ZIMV) - Future Price to Earnings|Projected Price to Earnings AngioDynamics|CERS (cerus.com) - Forward P/E Multiple|Projected Price to Earnings Ratio Teknova Inc TKNO|Future Price to Earnings Monogram Orthopedics (MGRM)|Sharps Tech - Price to Future Earnings Ratio|InfuSystem Holdings, Inc. - Projected Price to Earnings|Market Cap to Future Earnings Ratio UTMD (Utah Medical Products Inc.)|KRMD - Future Price to Earnings|Market Cap to Projected Earnings Nyxoah S.A NYXH|microbotmedical.com (MBOT) - Future Price to Earnings|Price to Expected Earnings Ratio PDEX (pro-dex.com)|ZTEK (Zentek Corp) - Forward P/E Multiple|Future Price to Earnings ELUT|Future Price to Earnings Milestone Scientific Corp (MLSS)|NEXGEL, Inc - Price to Future Earnings Ratio|Forward P/E Multiple RVP (Retractable Technologies Inc.)|Harvard Bioscience, Inc. - Future Price to Earnings|FEMY - Future Price to Earnings|MHUA - Forward P/E Multiple|POAI: Forward P/E Multiple|Price to Future Earnings Ratio CJMB|Projected Price to Earnings ATRI|Projected Price to Earnings Ratio NeuroMetrix NURO